HOLD THAT SWAB: The FDA is taking issue with the lack of scientific evidence presented by 23andMe to support the conclusions it draws from its personal genomics test kits.© WILLSIE/ISTOCKPHOTO.COM
—Alberto Gutierrez, director of the FDA’s Office of In Vitro Diagnostics and Radiological Health, in a letter to 23andMe CEO Ann Wojcicki, telling her that the company must stop marketing its genomic testing kits or face FDA sanctions (November 22)
—Oxford University grad student Rahul Rekhi, in an opinion piece for The Guardian about the FDA’s letter to 23andMe (December 4)
—Science writer and New York University research psychologist Gary Marcus, in a New Yorker blog post on why science has its critics (November 7)
—L. Val Giddings, senior fellow at the Information Technology and Innovation Foundation, on the need to prepare agriculture for changes wrought by climate change (as quoted in The New York Times, November 11)
—Duke University biologist Gregory Wray, as quoted ...
